Optical Genome Mapping for copy number alterations, aneuploidy, and balanced/complex structural rearrangements in Hematological Malignancies
Hematologic malignancies are frequently driven by chromosomal abnormalities including translocations, inversions, deletions, duplications, and aneuploidy. These aberrations activate oncogenic pathways and influence prognosis and therapy selection.
Conventional karyotyping remains a cornerstone for detecting structural chromosomal changes but has limited resolution and may miss cryptic or balanced rearrangements. Optical Genome Mapping (OGM) is an advanced imaging technique that uses fluorescent labeling of ultra-long DNA molecules to detect structural variants (SVs) and copy number variants (CNVs) across the genome with high sensitivity, down to 500 base pairs.
A key advantage of OGM is its ability to detect clinically relevant aberrations, such as the DEK::NUP214 translocation seen in myeloid neoplasms, which are often missed by standard cytogenetic methods. OGM is especially valuable in cases of complex karyotypes where traditional approaches are inconclusive. Compared with conventional methods (karyotyping, FISH, CMA), OGM provides a more comprehensive genomic profile, supporting accurate diagnosis, personalized risk assessment, prognostic evaluation, and therapeutic guidance.
- Identifies chromosomal aberrations underlying hematologic malignancies
- Aids in diagnosis, lineage classification, and risk stratification
- Supports therapeutic decision-making and targeted therapy selection
- Facilitates disease monitoring and assessment of clonal evolution
Not applicable
Heparinized peripheral blood, Bone marrow, amniotic fluid, or solid tissue.
Stability
Specimen should be processed within 24 hours.
- Am J Hematol. 2022 Jul;97(7):975-982. doi: 10.1002/ajh.26587. [PMID: 35560245]
- Am J Hum Genet. 2021 Aug 5;108(8):1423-1435. [PMID: 34237281]
- J Assoc Genet Technol. 2021;47(4):191-200. [PMID: 34897113]
- Genes (Basel). 2021 Mar 11;12(3):398. [PMID: 33799648]